Maintenance / Service
PRODUCTS
-
Discover better logistics support for the pharmaceutical, biotechnology, and medical device industries with high-quality kit packing and distribution through in-house kit-building facilities.
-
Optimizing expression of RNA therapies. Go from sequence to validated candidates in a matter of weeks.
-
From product development to translation into clinical trials, GTx’s clinically validated scalable electroporation technology is equipped to handle your most complex cellular engineering demands.
- Rapidly transfect from 75 thousand to 20 billion cells
- Move forward with 21 CFR Part 11 enabled software
- Develop quickly with an established regulatory path supported by a FDA Master File
- Manufacture confidently with closed, cGMP-compliant, ISO-certified and CE-marked products
- Enjoy MaxCyte’s proprietary Flow Electroporation® technology
-
A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.
-
Edge Blackening is the application of a matte black paint to the edges of an optical filter to prevent stray light inside the filter from re-entering the light path outside the filter.
WHITE PAPERS AND CASE STUDIES
-
Modernizing Operational Maintenance At Treatment Plants
In 2017, the Harford County Division of Water and Sewer began looking for a modern work management solution to help automate preventive maintenance, coordinate work activities between groups, manage material inventories, and capture important data.
-
Phase 1 Clinical Trial Designs And Strategies
With tailored guidance, sponsors can align their modern model-based and model-assisted design choices to program goals, accelerating progress while safeguarding patients.
-
Electronic Batch Reporting
Learn how a CDMO automatically created a comprehensive batch report model to drive their reporting and speed root cause identification of quality failures with an Industrial DataOps software solution.
-
The Untapped Power Of Real-World Data And AI In Pharma Commercialization
Harnessing RWD in commercialization bridges the gap between approval and patient access, equipping companies with actionable intelligence to deliver life-changing therapies to more patients.
-
Increasing Participation In World-Class Cancer Research In Northwest Arkansas
Discover how data automation and integrated screening help community cancer centers offer clinical research as a standard care option, ensuring all patients have access to the latest treatments.
-
The Answer To Your Pharmacovigilance Challenges: AI-Powered Adverse Event Detection
A proven, AI-powered safety platform can accelerate adverse event detection and safety data extraction to ease the burden on safety professionals and better protect patients.
-
eCOA: Unified Approach Streamlines Processes, Speeds Start Up And Improves Data Quality
Discover how a leading biopharmaceutical company revolutionized its clinical development with an eCOA solution that optimized its processes, cut build times, and enhanced data quality.
-
Contamination In The Shadows: Risks Lurking From Environmental Issues
Discover how science-based bio-decontamination strategies effectively eliminate invisible pathogens and rapidly restore facilities to operational safety following major infrastructure disruptions.
-
Digital Solutions Enhance Pharmaceutical Manufacturing Performance
Personalised therapies and advanced technologies are reshaping manufacturing. Explore how intelligent automation can improve flexibility, strengthen data integrity, and accelerate production.
-
Unlock The Power Of Clinical Data Science
Discover a unified, AI‑driven approach that helps clinical teams manage growing data complexity, accelerate insight generation, and improve trial oversight to enable faster decisions.
-
Beyond The Benchmark: Innovative Trial Designs Transform Research
Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
NEWS
-
Citybox Adopts Mews To Streamline Operations And Scale Innovation Across The Nordics2/4/2026
Fast-growing Norwegian hotel group, Citybox, has selected Mews, the leading operating system for hospitality and shared spaces, as its property management system to power its multi-country portfolio and accelerate the brand’s mission to deliver the most seamless customer experience in the industry.
-
Grifols And Inpeco Joining Forces To Deliver Transfusion Medicine 'Lab Of The Future'3/20/2025
Grifols a global healthcare company and leading manufacturer of plasma-derived medicines and innovative diagnostic solutions, today announced it has signed a strategic agreement with Inpeco, a global leader in total laboratory automation technologies, to provide transfusion medicine labs with complete, tailored instrumentation, robotics and software capabilities to modernize their operations and make them more efficient.
-
Neochromosome And Opentrons Introduce Automated Antibody Discovery Solution, Enabling Labs To Achieve Rapid, Cost-Effective In-House Development4/29/2025
Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its subsidiary specializing in products unlocked through genome-scale cell engineering, today announced the Opentrons Flex neoSwitch Workstation powered by the Neochromosome neoSwitch platform for in-house antibody discovery.
-
How Fairgrounds (Previously AgPile) Connects Data And Crop Breeders – With Early Examples8/27/2025
In early 2025, CGIAR received a grant from the Gates Foundation to develop AgPile, a FAIR, federated and collaborative data platform that references and organizes access to datasets from CGIAR, its Centers, and partners.
-
Eckert & Ziegler And GlyTherix Extend Collaboration With Actinium-225 Supply Agreement1/13/2025
Eckert & Ziegler and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today announced the expansion of their existing Lutetium-177 based collaboration with a global supply agreement for Actinium-225 (Ac-225).